Research Seed Capital (RiSC) awarded to IZI-IBBS cross-disciplinary project

September 28, 2021

The fund will be used to pioneer a bone metastasis risk profiling platform for personalized treatment of breast cancer patients. To this end high-precision 3D-printed bone niches of various topographies will be used to interrogate their colonization by aggressive human breast cancer cells in vitro. The two-year project is coordinated by Cristiana Lungu (Olayioye group, IZI) and builds on the close collaboration with the teams of Marcel Hörning and Michael Heymann (IBBS).



To the top of the page